Toxicogenomics:  Variety of Technologies for Omics Data Generation: Limits and Recommendation for Safety Evaluation of Cosmetic Ingredients

Compare three transcriptomics technologies for two chemical families in vitro to: 

• Characterize each technology to allow for in-depth comparison
• Generate data on a collection of two chemical families on one cell line and three technologies
• Calculate Cmap and PoD (capitalize on ongoing project) 
• Compare results: values, uncertainties, and beside data: capacity to handle and cost